Bloom Burton Stock Recommendations and Price Targets

This is a list of recent ratings by Bloom Burton.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
11/15/2021
TMD
Titan Medical
DowngradeC$1.00Buy ➝ AccumulateN/A
11/15/2021
TMDI
Titan Medical
Downgrade$1.00Buy ➝ AccumulateHigh
10/5/2021
GBNH
Greenbrook TMS
Reiterated Rating$5.00 $16.00BuyMedium
10/1/2021
AUPH
Aurinia Pharmaceuticals
Initiated Coverage$20.00 $23.00HoldMedium
10/1/2021
TRIL
Trillium Therapeutics
Initiated Coverage$18.00 $18.50Buy ➝ HoldLow
9/30/2021
RPTX
Repare Therapeutics
Initiated Coverage$23.00 $49.00BuyLow
9/22/2021
MDNA
Medicenna Therapeutics
Initiated CoverageC$2.00 C$11.00BuyN/A
9/22/2021
MDNA
Medicenna Therapeutics
Initiated Coverage$2.00 $11.00BuyMedium
8/13/2021
BLU
BELLUS Health
Reiterated Rating$6.00BuyLow
8/13/2021
BLU
BELLUS Health
Reiterated RatingC$7.00BuyN/A
8/5/2021
HLS
HLS Therapeutics
Reiterated RatingC$15.00BuyN/A
8/4/2021
MDP
Pediapharm
DowngradeC$3.00Buy ➝ HoldN/A
8/4/2021
VMD
Viemed Healthcare
UpgradeC$7.00Accumulate ➝ BuyN/A
8/4/2021
VMD
Viemed Healthcare
Upgrade$6.00Accumulate ➝ BuyLow
8/4/2021
VMD
Viemed Healthcare
Upgrade$6.00Accumulate ➝ BuyLow
6/14/2021
KDNY
Chinook Therapeutics
Reiterated Rating$16.00 $40.00BuyLow
5/7/2021
AUPH
Aurinia Pharmaceuticals
Upgrade$20.00Accumulate ➝ BuyHigh
5/7/2021
AUP
Aurinia Pharmaceuticals
UpgradeC$17.00Accumulate ➝ BuyN/A
4/29/2021
TRIL
Trillium Therapeutics
Upgrade$18.00Accumulate ➝ BuyMedium
4/19/2021
TMD
Titan Medical
Reiterated RatingC$1.00BuyN/A
4/19/2021
TMDI
Titan Medical
Reiterated Rating$1.00BuyHigh
4/9/2021
GBNH
Greenbrook TMS
Reiterated Rating$5.00 $16.00BuyLow
3/26/2021
GUD
Knight Therapeutics
UpgradeC$5.00Accumulate ➝ BuyN/A
3/22/2021
KDNY
Chinook Therapeutics
Reiterated Rating$16.00BuyHigh
3/18/2021
RX
BioSyent
DowngradeC$9.00Accumulate ➝ HoldN/A
2/23/2021
MDP
Medexus Pharmaceuticals
UpgradeC$8.00Accumulate ➝ BuyN/A
2/12/2021
EPIX
ESSA Pharma
Reiterated Rating$13.00BuyN/A
1/29/2021
LMNL
Liminal BioSciences
Downgrade$1.00Hold ➝ SellLow
12/17/2020
FUSN
Fusion Pharmaceuticals
Reiterated Rating$5.00BuyMedium
12/8/2020
TRIL
Trillium Therapeutics
Downgrade$18.00Buy ➝ AccumulateHigh
11/17/2020
MRVFF
Nuvo Pharmaceuticals
Reiterated RatingC$1.00BuyN/A
11/3/2020
AUPH
Aurinia Pharmaceuticals
Downgrade$20.00Buy ➝ AccumulateLow
11/3/2020
AUP
Aurinia Pharmaceuticals
DowngradeC$17.00Buy ➝ AccumulateN/A
10/19/2020
VMD
Viemed Healthcare
Reiterated RatingC$7.00AccumulateN/A
10/19/2020
VMD
Viemed Healthcare
Reiterated Rating$6.00AccumulateHigh
10/19/2020
VMD
Viemed Healthcare
Reiterated Rating$6.00AccumulateHigh
10/6/2020
CPHRF
Cipher Pharmaceuticals
Reiterated Rating$1.00 $2.00BuyLow
10/5/2020
LMNL
Liminal BioSciences
Reiterated Rating$1.00HoldLow
9/17/2020
RPTX
Repare Therapeutics
Reiterated Rating$23.00BuyHigh
8/24/2020
MDNA
Medicenna Therapeutics
Reiterated Rating$2.00BuyMedium
8/21/2020
HTL
Hamilton Thorne
Reiterated RatingC$2.00BuyN/A
8/16/2020
CPHRF
Cipher Pharmaceuticals
Reiterated Rating$1.00 $2.00BuyLow
8/14/2020
CRH
CRH
Reiterated Rating$51.00BuyLow
8/13/2020
XENE
Xenon Pharmaceuticals
Reiterated Rating$26.00 $25.00BuyMedium
7/21/2020
HLS
HLS Therapeutics
UpgradeC$15.00Accumulate ➝ BuyN/A
6/29/2020
GUD
Knight Therapeutics
DowngradeC$5.00Buy ➝ AccumulateN/A
6/14/2020
ZYME
Zymeworks
Reiterated Rating$18.00BuyLow
5/24/2020
EPIX
ESSA Pharma
Reiterated Rating$13.00 $9.00BuyHigh
5/8/2020
CPH
Cipher Pharmaceuticals
UpgradeC$2.00Hold ➝ AccumulateN/A
3/31/2020
HLS
HLS Therapeutics
DowngradeC$15.00Buy ➝ AccumulateN/A
3/19/2020
AUPH
Aurinia Pharmaceuticals
Reiterated Rating$20.00 $23.00BuyLow
3/19/2020
RX
BioSyent
DowngradeC$9.00Buy ➝ AccumulateN/A
11/12/2019
MRVFF
Nuvo Pharmaceuticals
UpgradeC$1.00Hold ➝ BuyN/A
10/22/2019
GUD
Knight Therapeutics
UpgradeC$5.00Accumulate ➝ BuyN/A
10/2/2019
AUPH
Aurinia Pharmaceuticals
Reiterated Rating$20.00BuyLow
10/2/2019
AUP
Aurinia Pharmaceuticals
Reiterated RatingC$17.00BuyN/A
9/6/2019
BLU
BELLUS Health
Reiterated Rating$6.00BuyLow
8/26/2019
RX
BioSyent
UpgradeC$9.00Accumulate ➝ BuyN/A
8/12/2019
CPH
Cipher Pharmaceuticals
Reiterated RatingC$2.00HoldN/A
8/1/2019
BLU
BELLUS Health
Reiterated RatingC$7.00BuyN/A
7/3/2019
MDP
Medexus Pharmaceuticals
Reiterated RatingC$8.00AccumulateN/A
5/16/2019
MRVFF
Nuvo Pharmaceuticals
DowngradeC$1.00Buy ➝ HoldN/A
4/1/2019
MRVFF
Nuvo Pharmaceuticals
Reiterated RatingC$1.00BuyN/A
3/20/2019
CPH
Cipher Pharmaceuticals
Reiterated RatingC$2.00BuyN/A
3/15/2019
CXRXF
ADVANZ PHARMA
Reiterated Rating$17.00HoldLow